Make new drugs from US, Europe available to DMD patients here, urges advocate

Coalition Duchenne expedition participants with Sabah Tourism, Culture and Environment ministry officials, state representatives and others at the flagging-off ceremony.

KOTA KINABALU: New drugs and treatment for Duchenne muscular dystrophy (DMD) from the United States and Europe should be made accessible to patients in Malaysia, says advocate Catherine Jayasuriya.

The founder of Coalition Duchenne said treatments such as gene therapy would initially cost over US$3.5mil (RM16.34mil) per patient, and such costs were too high for many.